Literature DB >> 30614881

Randomized Trial of Near-infrared Incisionless Fluorescent Cholangiography.

Fernando Dip1,2, Emanuelle LoMenzo1, Luis Sarotto1, Edward Phillips3, Hernan Todeschini1, Mario Nahmod1, Lisandro Alle1, Sylke Schneider4, Ludwig Kaja4, Luigi Boni5, Pedro Ferraina1, Thomas Carus6, Norihiro Kokudo7, Takeaki Ishizawa7, Mathew Walsh8, Conrad Simpfendorfer2, Roy Mayank2, Kevin White9, Raul J Rosenthal2.   

Abstract

BACKGROUND: Incisionless near-infrared fluorescent cholangiography (NIFC) is emerging as a promising tool to enhance the visualization of extrahepatic biliary structures during laparoscopic cholecystectomies.
METHODS: We conducted a single-blind, randomized, 2-arm trial comparing the efficacy of NIFC (n = 321) versus white light (WL) alone (n = 318) during laparoscopic cholecystectomy. Using the KARL STORZ Image1 S imaging system with OPAL1 technology for NIR/ICG imaging, we evaluated the detection rate for 7 biliary structures-cystic duct (CD), right hepatic duct (RHD), common hepatic duct, common bile duct, cystic common bile duct junction, cystic gallbladder junction (CGJ), and accessory ducts -before and after surgical dissection. Secondary calculations included multivariable analysis for predictors of structure visualization and comparing intergroup biliary duct injury rates.
RESULTS: Predissection detection rates were significantly superior in the NIFC group for all 7 biliary structures, ranging from 9.1% versus 2.9% to 66.6% versus 36.6% for the RHD and CD, respectively, with odds ratios ranging from 2.3 (95% CI 1.6-3.2) for the CGJ to 3.6 (1.6-9.3) for the RHD. After dissection, similar intergroup differences were observed for all structures except CD and CGJ, for which no differences were observed. Significant odds ratios ranged from 2.4 (1.7-3.5) for the common hepatic duct to 3.3 (1.3-10.4) for accessory ducts. Increased body mass index was associated with reduced detection of most structures in both groups, especially before dissection. Only 2 patients, both in the WL group, sustained a biliary duct injury.
CONCLUSIONS: In a randomized controlled trial, NIFC was statistically superior to WL alone visualizing extrahepatic biliary structures during laparoscopic cholecystectomy. REGISTRATION NUMBER: NCT02702843.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30614881     DOI: 10.1097/SLA.0000000000003178

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  Incisionless fluorescent cholangiography (IFC): a pilot survey of surgeons on procedural familiarity, practices, and perceptions.

Authors:  Fernando Dip; Luis Sarotto; Mayank Roy; Aaron Lee; Emanuelle LoMenzo; Matthew Walsh; Thomas Carus; Sylke Schneider; Luigi Boni; Takeaki Ishizawa; Nohiro Kokudo; Kevin White; Raul J Rosenthal
Journal:  Surg Endosc       Date:  2019-05-06       Impact factor: 4.584

2.  Effectiveness of near-infrared fluorescent cholangiography in the identification of cystic duct-common hepatic duct anatomy in comparison to magnetic resonance cholangio-pancreatography: a preliminary study.

Authors:  Antonio Pesce; Gaetano La Greca; Luca Esposto Ultimo; Antonio Basile; Stefano Puleo; Stefano Palmucci
Journal:  Surg Endosc       Date:  2019-10-09       Impact factor: 4.584

3.  Is it still reasonable to raise doubts on ICG-fluorescence cholangiography during laparoscopic cholecystectomy?

Authors:  Antonio Pesce; Gaetano La Greca
Journal:  Updates Surg       Date:  2020-06-14

4.  Routine near infra-red indocyanine green fluorescent cholangiography versus intraoperative cholangiography during laparoscopic cholecystectomy: a case-matched comparison.

Authors:  Silvia Quaresima; Andrea Balla; Livia Palmieri; Ardit Seitaj; Abe Fingerhut; Pietro Ursi; Alessandro M Paganini
Journal:  Surg Endosc       Date:  2019-07-15       Impact factor: 4.584

Review 5.  Application of indocyanine green (ICG)-guided surgery in clinical practice: lesson to learn from other organs-an overview on clinical applications and future perspectives.

Authors:  E Cassinotti; L Boni; L Baldari
Journal:  Updates Surg       Date:  2022-10-06

6.  Feasibility and comparison of laparoscopic laser speckle contrast imaging to near-infrared display of indocyanine green in intraoperative tissue blood flow/tissue perfusion in preclinical porcine models.

Authors:  Chibueze A Nwaiwu; Vasiliy E Buharin; Anderson Mach; Robin Grandl; Matthew L King; Alyson F Dechert; Liam O'Shea; Steven D Schwaitzberg; Peter C W Kim
Journal:  Surg Endosc       Date:  2022-09-16       Impact factor: 3.453

Review 7.  The Evolution of Fluorescence-Guided Surgery.

Authors:  Stan Van Keulen; Marisa Hom; Haley White; Eben L Rosenthal; Fred M Baik
Journal:  Mol Imaging Biol       Date:  2022-09-19       Impact factor: 3.484

8.  Intracholecystic versus Intravenous Indocyanine Green (ICG) Injection for Biliary Anatomy Evaluation by Fluorescent Cholangiography during Laparoscopic Cholecystectomy: A Case-Control Study.

Authors:  Lidia Castagneto-Gissey; Maria Francesca Russo; Alessandra Iodice; James Casella-Mariolo; Angelo Serao; Andrea Picchetto; Giancarlo D'Ambrosio; Irene Urciuoli; Alessandro De Luca; Bruno Salvati; Giovanni Casella
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

9.  Routine use of ICG to enhance operative safety in emergency laparoscopic cholecystectomy: a randomized controlled trial.

Authors:  Wong Hoi She; Tan To Cheung; Miu Yee Chan; Ka Wan Chu; Ka Wing Ma; Simon H Y Tsang; Wing Chiu Dai; Albert C Y Chan; Chung Mau Lo
Journal:  Surg Endosc       Date:  2022-02-22       Impact factor: 3.453

Review 10.  Systematic review of the role of indocyanine green near-infrared fluorescence in safe laparoscopic cholecystectomy (Review).

Authors:  Dragos Serban; Dumitru Cristinel Badiu; Dragos Davitoiu; Ciprian Tanasescu; Mihail Silviu Tudosie; Alexandru Dan Sabau; Ana Maria Dascalu; Corneliu Tudor; Simona Andreea Balasescu; Bogdan Socea; Daniel Ovidiu Costea; Anca Zgura; Andreea Cristina Costea; Laura Carina Tribus; Catalin Gabriel Smarandache
Journal:  Exp Ther Med       Date:  2021-12-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.